686 related articles for article (PubMed ID: 18973179)
21. The role of surgery in the management of recurrent adrenocortical carcinoma.
Erdogan I; Deutschbein T; Jurowich C; Kroiss M; Ronchi C; Quinkler M; Waldmann J; Willenberg HS; Beuschlein F; Fottner C; Klose S; Heidemeier A; Brix D; Fenske W; Hahner S; Reibetanz J; Allolio B; Fassnacht M;
J Clin Endocrinol Metab; 2013 Jan; 98(1):181-91. PubMed ID: 23150691
[TBL] [Abstract][Full Text] [Related]
22. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
24. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
25. Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes.
O'Neill CJ; Spence A; Logan B; Suliburk JW; Soon PS; Learoyd DL; Sidhu SB; Sywak MS
J Surg Oncol; 2010 Oct; 102(5):450-3. PubMed ID: 20734420
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
27. Experience with the surgical treatment of adrenal cortical carcinoma.
Meyer A; Niemann U; Behrend M
Eur J Surg Oncol; 2004 May; 30(4):444-9. PubMed ID: 15063900
[TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
Sugitani I; Fujimoto Y; Yamamoto N
Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
[TBL] [Abstract][Full Text] [Related]
29. [Adrenocortical carcinoma. Current approaches in diagnosis and treatment].
Sapienza P; Tedesco M; Burchi C; Battistini M; Cavallaro A
Ann Ital Chir; 1995; 66(5):651-63. PubMed ID: 8948804
[TBL] [Abstract][Full Text] [Related]
30. Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes.
Kendrick ML; Curlee K; Lloyd R; Farley DR; Grant CS; Thompson GB; Rowland C; Young WF; van Heerden JA
Surgery; 2002 Dec; 132(6):1008-11; discussion 1012. PubMed ID: 12490848
[TBL] [Abstract][Full Text] [Related]
31. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
32. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
33. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.
Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070
[TBL] [Abstract][Full Text] [Related]
34. Surgical management and clinical prognosis of adrenocortical carcinoma.
Dong D; Li H; Yan W; Ji Z; Mao Q
Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
[TBL] [Abstract][Full Text] [Related]
35. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
36. Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.
Canter DJ; Mallin K; Uzzo RG; Egleston BL; Simhan J; Walton J; Smaldone MC; Master VA; Bratslavsky G; Kutikov A
Can J Urol; 2013 Oct; 20(5):6915-21. PubMed ID: 24128829
[TBL] [Abstract][Full Text] [Related]
37. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
[TBL] [Abstract][Full Text] [Related]
38. Adrenocortical carcinoma: clinical and laboratory observations.
Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
[TBL] [Abstract][Full Text] [Related]
39. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
40. Adenoid cystic carcinoma of the submandibular gland: a 35-year review.
Cohen AN; Damrose EJ; Huang RY; Nelson SD; Blackwell KE; Calcaterra TC
Otolaryngol Head Neck Surg; 2004 Dec; 131(6):994-1000. PubMed ID: 15577803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
